70 results
Effect of alcohol-mediated renal denervation on blood pressure in the presence of antihypertensive drugs: 3-month primary results from the TARGET BP I Randomized Trial
08 Apr 2024
Alessandro Sticchi interviews David E. Kandzari about the results of the Target Bp I Randomized Trial which he presented at ACC.24.
The trial reports mixed results on nerve ablation for high blood pressure with a modest but statistically significant difference in lowered blood pressure at 3 months,...
Author
Author
Renal denervation 2.0 - Ready for clinical use?
06 Dec 2023 – From GulfPCR-GIM 2023
Stay updated on the latest clinical evidence, guidelines, and technology related to renal denervation. Engage in discussions about the clinical experiences with ultrasound renal denervation (uRDN) and gain practical insights into selecting patients through real-world cases.
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
Intervention around arterial hypertension
18 May 2023 – From EuroPCR 2023
Explore the realm of interventions in the context of arterial hypertension in this session: witness the remote haemodynamic monitoring of heritable pulmonary arterial hypertension, uncover the case of unilateral renal atrophy four years after renal sympathetic denervation, break the "boundaries" posed by calcification in renovascular hypertension,...
Innovations in device-based treatment for hypertension
17 May 2023 – From EuroPCR 2023
Join this session to explore the latest innovations in device-based treatment for hypertension. Gain a comprehensive understanding of the evidence supporting the efficacy, durability, and safety of radiofrequency renal denervation, learn from renowned experts about the renal denervation procedure and receive valuable insights on patient selection...
EuroPCR 2023 Hotlines/Late-Breaking Trials: TAVI, hypertension, stroke prevention
17 May 2023 – From EuroPCR 2023
Want to find out what's happened lately in the field of hypertension and stroke prevention with TAVI? Check out this session where speakers give their take on what's essential to remember from a selection of studies: Primary outcome of the AnchorMan LAAO device randomised controlled trial...
Patient selection for renal denervation in 2023
17 May 2023 – From EuroPCR 2023
While many clinical studies have demonstrated the superiority of renal denervation, the question that Felix Mahfoud asks Michel Azizi is when and in which patients to use this technique. Referring to the new consensus guidelines, our hypertension expert provides some answers in this exclusive interview recorded during EuroPCR 2023....
From proof to practice - Treating hypertension with ultrasound renal denervation
16 May 2023 – From EuroPCR 2023
Renal denervation: what are the latest clinical evidences and benefits? How to select the good candidate? How to establish a dedicated centre? All the anwers to these questions and more in this video.
Update on renal denervation
16 May 2023 – From EuroPCR 2023
Check out these slides if you want to refresh your memory regarding this session presenting an update on renal denervation.
Renal denervation in the management of hypertension in adults: Consensus Document
15 Feb 2023
A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). The current position paper reviews the evidence for the safety and efficacy of renal denervation (RDN), summarizes aspects of the Expert Group’s discussion, and provides consensus statements...
Reviewer
